MarginsXMarginsX
Home › Data Desk › ARCH Venture Fund X, L.P. discloses a 12.9% stake in Aspen Neuroscience Inc.

MarginsX Data Desk · 13D stakes

ARCH Venture Fund X, L.P. discloses a 12.9% stake in Aspen Neuroscience Inc.

ARCH Venture Fund X, L.P. filed a Schedule 13D on Nov 9, 2026, reporting 3.8 million shares of Aspen Neuroscience Inc. (ASPE), 12.9% of the class, as of Nov 2, 2026. (SEC EDGAR, SCHEDULE 13D, Nov 9, 2026)

By the MarginsX Data Desk, automated. Published November 14, 2026. Data as of November 9, 2026.

Abstract illustration: a boardroom table from above, seats as rounded shapes, one highlighted.

What the filer says it intends

On the purpose of the transaction, the filing says: “AVF X, AVF X Overage, AVF XIV and the other Reporting Persons acquired the Common Stock for investment purposes. Depending on market conditions, the continuing evaluation of the business and prospects of the Issuer and other factors, AVF X, AVF X Overage, AVF XIV and other Reporting Persons may dispose …” (SEC EDGAR, SCHEDULE 13D, Nov 9, 2026)

The stock

The Nasdaq screener puts its market value at $395.8M. (Nasdaq stock screener, Nov 13, 2026)

Frazier Life Sciences X, L.P. passes 5.0% of Aspen Neuroscience Inc.

In a Schedule 13G filed Nov 9, 2026, Frazier Life Sciences X, L.P. reported 1.7 million shares of Aspen Neuroscience Inc. (ASPE) as of Nov 2, 2026, 5.8% of the class. (SEC EDGAR, SCHEDULE 13G, Nov 9, 2026)

Follow it up

The company's page on MarginsX, with its filings, health check and ownership. (capital.sophiaxt.com/stocks/ASPE)

The filing on SEC EDGAR. (sec.gov)

The filing in the MarginsX reader. (MarginsX reader)

Automated from SEC filings and market data by the MarginsX Data Desk, written by template with no AI. For information only. Not investment advice.

Facts behind this article

FactValueSourceAs of
FilerARCH Venture Fund X, L.P.Source2026-11-09
Pct12.9 %Source2026-11-09
NameAspen Neuroscience Inc.Source2026-11-13
FormSchedule 13DSource2026-11-09
FiledNov 9, 2026Source2026-11-09
Shares3,754,922 sharesSource2026-11-09
WhoAspen Neuroscience Inc. (ASPE)Source2026-11-13
SymbolASPESource2026-11-13
Event dateNov 2, 2026Source2026-11-09
PurposeAVF X, AVF X Overage, AVF XIV and the other Reporting PersonSource2026-11-09
Cap395,759,746 USDSource2026-11-13
FormSchedule 13GSource2026-11-09
FilerFrazier Life Sciences X, L.P.Source2026-11-09
Shares1,674,321 sharesSource2026-11-09
Pct5.8 %Source2026-11-09

Sources

Automated from SEC filings and market data. No AI. For information only. Not investment advice.

Discuss in MarginsX More from the Data Desk

More on MarginsX

Companies in this article

Topics

Related Data Desk stories

Every Data Desk article: /desk · RSS